These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33933018)

  • 1. How to manage synchronous endometrial and ovarian cancer patients?
    Shin W; Park SY; Kang S; Lim MC; Seo SS
    BMC Cancer; 2021 May; 21(1):489. PubMed ID: 33933018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
    Oranratanaphan S; Manchana T; Sirisabya N
    Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
    Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
    J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.
    Chen L; Zhao Q; Lv X
    Arch Gynecol Obstet; 2011 May; 283(5):1133-7. PubMed ID: 20585952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in women with synchronous endometrial and ovarian cancers.
    Song T; Seong SJ; Bae DS; Kim JH; Suh DH; Lee KH; Park SY; Lee TS
    Int J Gynecol Cancer; 2014 Mar; 24(3):520-7. PubMed ID: 24552892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
    Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
    J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of endometrial cancer patients with positive lymph nodes.
    Brown AP; Gaffney DK; Dodson MK; Soisson AP; Belnap TW; Alleman K; Sause WT
    Int J Gynecol Cancer; 2013 Jun; 23(5):861-8. PubMed ID: 23598890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival.
    Williams MG; Bandera EV; Demissie K; Rodríguez-Rodríguez L
    Obstet Gynecol; 2009 Apr; 113(4):783-789. PubMed ID: 19305320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous primary endometrial and ovarian cancers: a multicenter review of 63 cases.
    Solmaz U; Karatasli V; Mat E; Dereli L; Hasdemir PS; Ekin A; Gezer C; Sayhan S; Sanci M; Guvenal T
    Tumori; 2016 Oct; 102(5):508-513. PubMed ID: 26166222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
    Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
    Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer in premenopausal women 45 years and younger.
    Gitsch G; Hanzal E; Jensen D; Hacker NF
    Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas.
    Rodolakis A; Thomakos N; Akrivos N; Sotiropoulou M; Ioannidis I; Haidopoulos D; Vlachos G; Antsaklis A
    Arch Gynecol Obstet; 2012 Mar; 285(3):817-21. PubMed ID: 21842403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries.
    Ayhan A; Guvenal T; Coskun F; Basaran M; Salman MC
    Eur J Gynaecol Oncol; 2003; 24(2):171-4. PubMed ID: 12701972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
    dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
    Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.